| 标题 |
Rationale and design of the AUSTRAL trial: An open-label, multicenter, phase II study evaluating radiotherapy followed by durvalumab (MEDI4736) and ceralasertib (AZD6738) in stage III NSCLC patients with thoracic relapses and/or oligometastases after the PACIFIC regimen |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Lung Cancer 作者:Andrea Riccardo Filippi; Eliana Rulli; Diego Signorelli; Jonas Willmann; André‐Dante Durham; et al 出版日期:2025-07-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)